(Biotechnology and Biological Sciences Research Council) Scientists have uncovered what happens to biomimetic nanoparticles when they enter human cells.
They found that the important proteins that make up the outer layer of these nanoparticles are degraded by an enzyme called cathepsin L.
Scientists now have to take this phenomenon into account and overcome this process to ensure the exciting field of nanomedicine can progress.
Post new comment